• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: T2 BIOSYSTEMS, INC T2BACTERIA PANEL; DIRECT BLOOD BACTERIAL NUCLEIC ACID DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

T2 BIOSYSTEMS, INC T2BACTERIA PANEL; DIRECT BLOOD BACTERIAL NUCLEIC ACID DETECTION SYSTEM Back to Search Results
Model Number T2BACTERIA PANEL
Device Problem False Positive Result (1227)
Patient Problem Insufficient Information (4580)
Event Date 07/07/2022
Event Type  malfunction  
Event Description
On (b)(6) 2022, a t2 distributor relayed a customer complaint of two clinical false positive results using the t2bacteria panel.
 
Manufacturer Narrative
T2 biosystems' distributor (italy) relayed a customer complaint that the t2bacteria panel resulted in two positive pseudomonas aeruginosa results on negative clinical samples after being run on t2dx instrument isa3317000134.After multiple inquiries by t2 biosystems, the customer refused to provide details associated with the reference assay that classified the false positive outcomes, patient details, or any impact to treatment.This is the first of two discrepant results.Specific run data was transferred to t2 biosystems for review/evaluation and a field service engineer (fse) was dispatched to the clinic on 20 july 2022; the t2bacteria panel and associated blood samples were discarded after use.The collective findings suggested an instrument failure (miscalibration) of the two instrument drawers where the false positive results were obtained, as well as non-optimal pump performance.The fse recalibrated and decontaminated the t2dx instrument during the 20 july 2022 visit.T2bacteria controls were run successfully and the system was released back to the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
T2BACTERIA PANEL
Type of Device
DIRECT BLOOD BACTERIAL NUCLEIC ACID DETECTION SYSTEM
Manufacturer (Section D)
T2 BIOSYSTEMS, INC
101 hartwell avenue
lexington MA 02421
Manufacturer (Section G)
T2 BIOSYSTEMS, INC
101 hartwell avenue
lexington MA 02421
Manufacturer Contact
bill jacques
101 hartwell avenue
lexington, MA 02421
7817614635
MDR Report Key15168201
MDR Text Key302494233
Report Number3010097867-2022-00028
Device Sequence Number1
Product Code QBX
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K172708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Distributor
Reporter Occupation Other Health Care Professional
Remedial Action Modification/Adjustment
Type of Report Initial
Report Date 08/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/17/2022
Device Model NumberT2BACTERIA PANEL
Device Catalogue Number80-07342
Device Lot Number20330
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/07/2022
Initial Date FDA Received08/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-